Posted 12/5/2023, 4:06:09 PM
Eli Lilly's New Obesity Drug Zepbound Now Available in U.S. by Prescription, Showing 3x Greater Weight Loss than Competitor in Studies
- Eli Lilly's obesity treatment, Zepbound (tirzepatide), now available in U.S. for obese or overweight adults via prescription
- Zepbound was approved by FDA in May 2022
- Added to national preferred drug formularies like Express Scripts and Cigna
- In studies, Zepbound 3x more effective for 15% weight loss than competitor semaglutide
- Lilly and competitor Novo Nordisk investing billions to expand obesity treatment manufacturing capacity